Abstract
Peritoneal dialysis (PD) is now widely and successfully used to treat end-stage renal disease (ESRD) patients. The continuous nature of the therapy and its home-based, self-care nature make it particularly advantageous for certain subgroups of patients. Using the peritoneal cavity as access provides additional uses of the therapy in both uraemic and nonuraemic states. This chapter focuses on the use of PD in special groups of ESRD patients and in a variety of non-uraemic conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Registration Committee of the European Dialysis and Tran-plant Association. Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol 1980; 87: 839–5.
Hou S. Peritoneal dialysis and hemodialysis in pregnancy. Baillieres Clin Obstet Gynecol 1987; 1: 1009–25.
Hou S. Pregnancy in women requiring dialysis for renal failure. Am J Kidney Dis 1987; 9: 368–73.
Lavoie SD, Johnson-Whittaker L, Huard PJ et al. Two successful pregnancies on CAPD. Adv Petit Dial 1988; 4: 90–5.
Gadallah MF, Ahmad B, Karubian F et al. Pregnancy in patients on chronic ambulatory peritoneal dialysis. Am J Kidney Dis 1992; 20: 407–410.
Hou S. Pregnancy in continuous ambulatory peritoneal dialysis (CAPD) patients. Petit Dial Int 1990; 10: 201–4.
Redav M, Cherem L, Eliot J et al. Dialysis in the management of pregnant patients with renal insufficiency. Medicine 1988; 67: 199.
Hou S, Orlowski J, Pahl M et al. Pregnancy in women with end-stage renal disease: treatment of anemia and premature labor. Am J Kidney Dis 1993; 21: 16–22.
Nagiotte MP, Grundg HO. Pregnancy outcome in women requiring chronic hemodialysis. Obstet Gynecol 1988; 72: 456–9.
Barri YM, Al Furayh O, Quinibi WY et al. Pregnancy in women on regular hemodialysis. Dial Transplant 1991; 20: 652–6.
Fujimi S, Hori K, Mujemd C et al. Successful pregnancy and delivery in a patient following r Hu EPO therapy and on long-term dialysis. J Am Soc Nephrol 1990; 1: 397 (abstract).
Okundaye I, Hou S. Results of pregnancy in patients undergoing dialysis. J Am Soc Nephrol 1995; 6: 398 (abstract).
Hou S. Pregnancy in women treated with peritoneal dialysis: viewpoint 1996. Petit Dial Int 1996; 16: 442–3.
Okundaye I, Hou S. Management of pregnancy in women undergoing ambulatory peritoneal dialysis. Adv Petit Dial 1996; 12: 151–5.
Jungers P, Chauveau D. Pregnancy in renal disease. Kidney Int 1997; 52: 871–85.
Bagon JA, Vernaeve H, De Muylder X, Lafontaine JJ, Martens J, Van Roost G. Pregnancy and dialysis. Am J Kidney Dis 1998; 31: 756–65.
Okundaye I, Abrinko P, Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis 1998; 31: 766–73.
Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis 1999; 33: 235–52.
Buehler N, Schreiber M, Moodley SJ et al. Successful pregnancy with APD. Petit Dial Int 1997; 17: S57 (abstract).
Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987; 316: 1062–8.
Gardenswartz MH, Lerau CW, Seligson AR et al. Renal disease in patients with AIDS: a clinicopathological study. Clin Nephrol 1984; 21: 197–204.
Nochy D, Glotz D, Dosquet P et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 1993; 8: 11–19.
Laradi A, Mallet A, Beaufils H, Allouach M, Martinez F. HIV-associated nephropathy: outcome and prognosis factors. J Am Soc Nephrol 1998; 9: 2327–35.
Humphreys MH. Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 1995; 48: 311–20.
Ifudu O, Mayers JD, Matthew JJ et al. Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s? Am J Kidney Dis 1997; 29: 549–52.
Breen C, Stein A, Hendry B. Outcome for patients with HIV-associated nephropathy on dialysis in the UK. J Am Soc Nephrol 1998; 9: 201A (abstract).
Perinbasekar S, Brod-Miller C, Pal S, Mattara J. Predictors of survival in HIV-infected patients on hemodialysis. Am J Nephrol 1996; 16: 280–6.
Cruz C, Kaul R, Markowitz N. Dialysis options for HIV infected patients. Petit Dial Int 1989; 9 (Suppl. 1): 89.
Graham MM, Bonini LA, Verdi MM. A multi-center study: clinical practices of HIV infected patients on CAPD/CCPD. Adv Petit Dial 1990; 3: 88–91.
Drissler R, Peters AT, Lynn RI. Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 1989; 86: 787–90.
Lewis M, Gorban-Brennan NL, Kliger A et al. Incidence and spectrum of organisms causing peritonitis in HIV positive patients on CAPD. Adv CAPD 1990; 6: 136–8.
Wasser WG, Beryl MJ, Brandons et al. HIV positivity does not predispose peritoneal dialysis patients to peritonitis. J Am Soc Nephrol 1991; 2: 369–73.
Schloth T, Genabe I, Pilgrim W et al. Peritonitis and the patient with human immunodeficiency virus (HIV). Adv Petit Dial 1992; 8: 250–2.
Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int 1993; 43: 191–8.
Wasser WG, Bajl MJ, Brandon S et al. HIV positivity does not predispose peritoneal dialysis patients to peritonitis. Petit Dial Int 1993; 13 (Suppl. 1): S88 (abstract).
Kimmel PL, Umana WO, Simmens SJ, Watson J, Bosch JP. Continuous ambulatory peritoneal dialysis and survival of HIV infected patients with end-stage renal disease. Kidney Int 1993; 44: 373–8.
Scheel, Jr. PJ, Farzadegan H, Ford D, Malan M, Watson A. Recovery of human immunodeficiency virus from peritoneal dialysis effluent. J Am Soc Nephrol 1995; 5: 1926–9.
Centre for Disease Control. Recommendations for providing dialysis treatment for patients infected with human-T-lymphotrophics virus type III/lymphadenopathy related virus. Ann Intern Med 1986; 106: 558–9.
MMWR. Recommendations for Prevention of HIV Transmission in Health Care Settings. 21 August 1987; 36: 25–185.
Chapman A, Wilkinson V, Peers EM, Brown CB. Intraperitoneal access for the treatment of peritonitis with AIDS. Petit Dial Int 1999; 19: S83 (abstract).
Wilkinson SP, Weston MJ, Parsons V et al. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol 1977; 8: 287–92.
Marcus RG, Messana J, Swartz R. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am J Med 1992; 93: 35–40.
Durand P-Y, Friedd P, Chanleau J et al. Long term follow up in cirrhotic patients with chronic renal failure undergoing CAPD. Petit Dial Int 1993; 13 (Suppl. 1): S47 (abstract).
Horie M, Kobayashi S. Nezassa S et al. A case report of hepatic cirrhosis with ascites and uremia treated by CAPD. Petit Dial Int 1993; 13 (Suppl. 1): S73 (abstract).
Macia M, del Castillo N, Pulido-Duque J, Garcia J. Successful maintenance CAPD in a diabetic patient with ascites and cavernous transformation of the portal vein. Petit Dial Int 1996; 16: 533–5.
Dadone C, Pincella G, Bonoldi G et al. Transport of water and solutes in uremic patients with chronic hepatic disease in CAPD. Adv Petit Dial 1990; 6: 23–5.
Steiner RW. Continuous equilibration peritoneal dialysis in acute renal failure. Petit Dial Int. 1989; 9: 5–7.
Cameron JS, Ogg CH, Trounce JR. Peritoneal dialysis in hypercatabolic acute renal failure. Lancet 1967; 1: 1188–91.
Posen GA, Luisello J. Continuous equilibration peritoneal dialysis in the treatment of acute renal failure. Petit Dial Bull 1981; 1: 6.
Katirtzoglous A, Kontesis P, Myopoulou-Symvoulidis D et al. Continuous equilibration peritoneal dialysis (CEPD) in hypercatabolic renal failure. Petit Dial Bull 1983; 3: 178–80.
Trevino-Becerra A, Munoz P, Avilez C et al. Equilibrium peritoneal dialysis (EPD) in acute renal failure (ARF) secondary to rhabdiomyolysis (sic). Petit Dial Bull 1987; 7: 244–6.
Siemons L, van den Heuvel P, Parizel G et al. Peritoneal dialysis in acute renal failure due to cholesterol embolization: two cases of recovery of renal function and extended survival. Clin Nephrol 1987; 28: 205–8.
Nolph KD. Peritoneal dialysis for acute renal failure. Trans Am Soc Artif Intern Organs 1988; 34: 54–5.
Hamilton JW, Lasrich M, Hergil P. Peritoneal dialysis in the treatment of severe hypercalcemia. J Dial 1980; 4: 129–35.
Heyburn PJ, Selby PL, Peacock M et al. Peritoneal dialysis in the management of severe hypercalcemia. Br Med J 1980; 280: 525–6.
Querfelf U, Salusky IB, Fine RN. Treatment of severe hypercalcemia with peritoneal dialysis in an infant with end-stage renal disease. Pediatr Nephrol 1988; 2: 323–5.
Weinreich T, Ritz E, Passlick-Deetjen J. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Petit Dial Int 1996; 16: 260–8.
Thompson TJ, Neale TJ. Intraperitoneal calcium for resistant symptomatic hypocalcaemia after parathyroidectomy in chronic renal failure. Br Med J 1988; 296: 896–7.
Benz RL, Schleifer CR, Teehan BP et al. Successful treatment of postparathyroidectomy hypocalcemia using continuous ambulatory intraperitoneal calcium (CAIC) therapy. Petit Dial Int 1989; 9: 285–8.
Mailloux LU, Swartz CD, Onesti G et al. Peritoneal dialysis for refractory congestive heart failure. JAMA 1967; 199: 873–8.
Nora JJ, Trygstad CW, Mangos JA et al. Peritoneal dialysis in the treatment of intractable congestive heart failure of infancy and childhood. J Pediatr 1966; 68: 693–8.
Cairns KB, Porter GA, Kloster FE et al. Clinical and hemodynamic results of peritoneal dialysis for severe cardiac failure. Am Heart J 1968; 76: 227–34.
Malach M. Peritoneal dialysis for intractable heart failure in acute myocardial infarction. Am J Cardiol 1972; 29: 61–3.
Raja RM, Krasnoff SO, Moros JG et al. Repeated peritoneal dialysis in treatment of heart failure. JAMA 1970; 213: 2268–9.
Shapira J, Lang R, Jutrin I et al. Peritoneal dialysis in refractory congestive heart failure. Part I: Intermittent peritoneal dialysis (IPD). Petit Dial Bull 1983; July-Sept: 130–2.
Weinrauch LA, Kaldany A, Miller DG et al. Cardiorenal failure: treatment of refractory biventricular failure by peritoneal dialysis. Uremia Invest 1984; 8: 1–8.
Robson M, Biro A, Knobel B et al. Peritoneal dialysis in refractory congestive heart failure. Part II: Continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Bull 1983; July-Sept: 133–4.
McKinnie JJ, Bourgeois RJ, Husserl FE. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis. Arch Intern Med 1985; 145: 1128–9.
Kim D, Khanna R, Wu G et al. Successful use of continuous ambulatory peritoneal dialysis in refractory heart failure. Petit Dial Bull 1985: 127–30.
Rubin J, Ball R. Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Arch Intern Med 1986; 146: 1533–5.
Shilo S, Slotki IN, Iaina A. Improved renal function following acute peritoneal dialysis in patients with intractable congestive heart failure. Isr J Med Sci 1987; 23: 821–4.
Mousson C, Tanter Y, Chalopin JM et al. Treatment of refractory congestive cardiac insufficiency by continuous ambulatory peritoneal dialysis. Long-term course. Presse Med 1988; 17: 1617–20.
Konig PS, Lhotta K, Kronenberg F et al. CAPD: a successful treatment in patients suffering from therapy_resistant congestive heart failure. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Petit Dial Bull Inc., 1991; 7: 97–101.
Stegmayr BG, Banga R, Lundberg L, Wikdahl AN, PlumWirell M. PD treatment for severe congestive heart failure. Petit Dial Int 1996; 16: S231–5.
Ryckelynck J-P, Lobbedez T, Valette B, Le Goff C, Mazouz O, Levaltier B, Potier J-C, Hurault de Ligny B. Peritoneal ultrafiltration and refractory congestive heart failure. Adv Petit Dial 1997; 13: 93–7.
Burton BK. Inborn errors of metabolism: the clinical diagnosis in early infancy. Pediatrics 1987; 79: 359–69.
Donn SM, Swartz RD, Thoene JG. Comparison of exchange transfusion, peritoneal dialysis and hemodialysis for the treatment of hyperammonemia in an anuric newborn infant. J Pediatr 1979; 95: 67–70.
Wiegand C, Thompson T, Bock GH et al. The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities. J Pediatr 1980; 96: 142–4.
Rutledge SL, Havens PL, Haymond MW et al. Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr 1990; 116: 125–8.
Siegel NJ, Brown RS. Peritoneal clearance of ammonia and creatinine in a neonate. J Pediatr 1973; 82: 1044–6.
Lettgen B, Bonze] KE, Colombo JP et al. Therapy of hyperammonemia in carbamyl phosphate synthase deficiency with peritoneal dialysis and venovenous hemofiltration. Monatsschr Kinderheilkd 1991; 139: 612–7.
Russell G, Thom H, Tarlow MJ et al. Reduction of plasma propionate by peritoneal dialysis. Pediatrics 1974; 53: 281–3.
Hsu WC, Lin SP, Huang FY et al. Propionic acidemia: report of a case that is successfully managed by peritoneal dialysis and sodium benzoate therapy. Chin Med J 1990; 46: 306–10.
Robert MF, Schultz DJ, Wolf B et al. Treatment of a neonate with propionic acidaemia and severe hyperammonemia by peritoneal dialysis. Arch Dis Child 1979; 54: 962–5.
Gortner L, Leupold D, Pohlandt F et al. Peritoneal dialysis in the treatment of metabolic crises caused by inherited disorders of organic and amino acid metabolism. Acta Paediats Scand 1989; 78: 706–11.
Sanjurjo P, Jaquotot C, Vallo A et al. Combined exchange transfusion and peritoneal dialysis treatment in a neonatal case of methylmalonic acidemia with severe hyperammonemia. An Esp Pediatr 1982; 17: 317–20.
Moreno-Vega A, Govantes JM. Methylmalonic acidemia treated by continuous ambulatory peritoneal dialysis (letter). N Engl J Med 1985; 312: 1641–2.
McMahon Y, MacDonnell RC Jr. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Petit Dial Bull Inc., 1990; 6: 31–4.
Sallan SE, Cottom D. Peritoneal dialysis in maple syrup urine disease. Lancet 1969; 635: 1423–4.
Clow CL, Reade TM, Scriver CR. Outcome of early and long-term management of classical maple syrup urine disease. Pediatrics 1981; 68: 856–62.
Vandepitte K, Lins RL, Daelemans R et al. Continuous ambulatory peritoneal dialysis (CAPD) in a patient with glucose-6-phosphatase deficiency. Petit Dial Int 1989; 9: 111–14.
Bunchman TE, Swartz RD. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD. Petit Dial Int 1994; 14: 81–4.
Lankisch PG, Koop H, Winckler K et al. Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the rat. II: analysis of its beneficial effect. Dig Dis Sci 1979; 24: 117–22.
Wall AJ. Peritoneal dialysis in the treatment of severe acute pancreatitis. Med J Aust 1965; 2: 281–3.
Rasmussen BL. Hypothermic peritoneal dialysis in the treatment of acute experimental hemorrhagic pancreatitis. Am J Surg 1967; 114: 716–21.
Bassi C, Briani G, Vesentini S et al. Continuous peritoneal dialysis in acute experimental pancreatitis in dogs. Effect of aprotinin in the dialysate medium. Int J Pancreatol 1989; 5: 69–75.
Lankisch PG, Koop H, Winckler K et al. Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the rat. I: Effect on length and rate of survival. Dig Dis Sci 1979; 24: 111–16.
Tilquin BM, O’Connor TC, Hancotte-LaHaye CM et al. The effect of peritoneal dialysis with and without aprotinin on acute experimental pancreatitis in rats. Int Surg 1990; 75: 174–8.
Fric P, Slaby J, Kosafirek E et al. Effective peritoneal therapy of acute pancreatitis in the rat with glutaryl-trialanin-ethylamide: a novel inhibitor of pancreatic elastase. Gut 1992; 33: 701–6.
Ranson JHC, Rifkind KM, Turner JW. Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 1976; 143: 209–19.
Ranson JHC, Spencer FC. The role of peritoneal lavage in severe acute pancreatitis. Ann Surg 1978; 187: 565–75.
Ranson JHC, Berman RS. Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis. Ann Surg 1990; 211: 708–18.
Stone HH, Fabian TC. Peritoneal dialysis in the treatment of acute alcoholic pancreatitis. Surg Gynecol Obstet 1980; 150: 878–82.
Mayer AD, McMahon MJ, Corfield AP et al. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. NEJM 1985; 312: 399–404.
Crist DW, Cameron JL. The current management of acute pancreatitis. Adv Surg 1987; 20: 69–123.
Joglar FM, Saadé M. Outcome and pancreatitis in CAPD and HD patients. Petit Dial Int 1995; 15: 264–73.
Ubara Y, Hara S, Katori H et al. Acute pancreatitis in a CAPD patient in association with hemolytic anemia. Petit Dial Int 1997; 17: 96–7.
Donnelly S, Levy M, Prichard S. Acute pancreatitis in continuous ambulatory peritoneal dialysis (CAPD). Petit Dial Int 1988; 8: 187–90.
Gupta A, Yi Yuan Z, Balaskas EV, Khanna R, Oreopoulos DG. CAPD and pancreatitis: no connection. Petit Dial Int 1992; 12: 309–16.
Moncade F, Fortier A, Guyon P et al. Peritoneal puncture dialysis in the monitoring and treatment of hemoperitoneum of traumatic origin? J Chir 1991; 128 (6_7): 285–9.
Delaitre B, Attailia A, Chibaoui M. Perforated gastroduodenal ulcers. Treatment by peritoneal dialysis. 72 cases. Presse Med 1988; 17: 1297–300.
McEvoy J, Kelly AMT. Psoriatic clearance during hemodialysis. Ulster Med J 1976; 45: 76–8.
Twardowski ZJ. Abatement of psoriasis and repeated dialysis (letter). Ann Intern Med 1977; 86: 509–10.
Twardowski ZJ, Nolph KD, Rubin J et al. Peritoneal dialysis for psoriasis. An uncontrolled study. Ann Intern Med 1978; 88: 345–51.
Hanicki Z, Cichocki T, Klein A et al. Dialysis for psoriasis–preliminary remarks concerning mode of action. Arch Dermatol Res 1981; 271: 401–5.
Goring HD, Thieler H, Guldner G et al. Peritoneal dialysis therapy in psoriasis. Hautarzt 1981; 32: 173–8.
Halevy S, Halevy J, Boner G et al. Dialysis therapy for psoriasis. Report of three cases and review of the literature. Arch Dermatol 1981; 117: 69–72.
Kramer P, Brunner FP, Brynger H et al. Dialysis treatment and psoriasis in Europe. Clin Nephrol 1982; 18: 62–8.
Whittier FC, Evans DH, Anderson PC et al. Peritoneal dialysis for psoriasis: a controlled study. Ann Intern Med 1983; 99: 165–8.
Glinski W, Jablonska S, Imiela J et al. Peritoneal dialysis and leukopheresis in psoriasis: indications and contraindications. Hautarzt 1985; 36: 16–19.
Twardowski ZJ, Lempert KD, Lankhorst BJ et al. Continuous ambulatory peritoneal dialysis for psoriasis. A report of four cases. Arch Intern Med 1986; 146: 1177–9.
Sobh MA, Abdel Rasik MM, Moustafa FE et al. Dialysis therapy of severe psoriasis: a random study of forty cases. Nephrol Dial Transplant 1987; 2: 351–8.
Nissenson AR, Rapaport M, Gordon A et al. Hemodialysis in the treatment of psoriasis: a controlled trial. Ann Intern Med 1979; 91: 218–20.
Goldsmith LA, Fisher M, Wacks J. Psychological characteristics of psoriasis: implications for management. Arch Dermatol 1969; 100: 674.
Anderson PC. Dialysis treatment of psoriasis (editorial). Arch Dermatol 1981; 117: 67–8.
Chen WT, Hu CH, Schiltz JR et al. In search of `psoriasis factor(s)’: a new approach by extracorporeal treatment. Artif Organs 1978; 2: 203–5.
Glinski W, Zarebska Z, Jablonska S et al. The activity of polymorphonuclear leukocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis. J Invest Dermatol 1980; 75: 481–7.
Glinski W, Jablonska S, Imiela J et al. Peritoneal dialysis and leukopheresis in psoriasis: indications and contraindications. Hautarzt 1985; 36: 16–19.
Krebs R, Flynn M. Treatment of hepatic coma with exchange transfusion and peritoneal dialysis. JAMA 1967; 199: 430–2.
Pirola RC, Ham JC, Elmslie RG. Management of hepatic coma complicating viral hepatitis. Gut 1969; 10: 898–903.
Mactier RA, Dobbie JW, Khanna R. Peritoneal dialysis in fulminant hepatic failure. Petit Dial Bull 1986; 6: 199–202.
Mactier R. Non-renal indications for peritoneal dialysis. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in Peritoneal Dialysis. Toronto: Petit Dial Bull Inc 1992.
Lash RF, Burdette JA, Ozdil T. Accidental profound hypothermia and barbiturate intoxication: a report of rapid `core’ rewarming by peritoneal dialysis. JAMA 1967; 201: 269–70.
Reuler JB, Parker RA. Peritoneal dialysis in the management of hypothermia. JAMA 1978; 240: 2289–90.
Moss JF, Haklin M, Southwick HW et al. A model for the treatment of accidental severe hypothermia. J Trauma 1986; 26: 68–74.
DaVee TS, Reineberg EJ. Extreme hypothermia and ventricular fibrillation. Ann Emerg Med 1980; 9: 100–2.
Davis FM, Judson JA. Warm peritoneal dialysis in the management of accidental hypothermia: report of five cases. NZ Med J 1981; 94: 207–9.
Troelsen S, Rybro L, Knudsen F. Profound accidental hypothermia treated with peritoneal dialysis. Scand J Urol Nephrol 1986; 20: 221–4.
Horowitz BZ. The golden hour in heat stroke: use of iced peritoneal lavage. Am J Emerg Med 1989; 7: 616–19.
Khan IH, Henderson IS, Mactier RA. Hyperpyrexia due to meningococcal septicaemia treated with cold peritoneal lavage. Postgrad Med J 1992; 68: 129–31.
Blye E, Lorch J, Cortell S. Extracorporeal therapy in the treatment of intoxication. Am J Kidney Dis 1984; 3: 321–38.
Schlegel RJ, Altstatt LB, Canales L et al. Peritoneal dialysis for severe salicylism: an evaluation of indications and results. J Pediatr 1966; 69: 553–62.
Arieff AI, Friedman EA. Coma following nonnarcotic drug overdosage: management of 208 adult patients. Am J Med Sci 1973; 266: 405–26.
Pross DC, Bradford WD, Krueger RP. Reye’s syndrome treated by peritoneal dialysis. Pediatrics 1970; 45: 845.
Shaw EB. Reye’s syndrome and salicylate intoxication. Pediatrics 1970; 46: 976–7.
Narcy P, Zorza G, Taburet AM et al. Severe poisoning with intravenous phenytoin in the newborn. Value of peritoneal dialysis. Arch Fran Pediatr 1990; 47: 591–3.
Roger SD, Crimmins D, Yiannikas C et al. Lead intoxication in an anurie patient: management by intraperitoneal EDTA. Aust NZ J Med 1990; 20: 814–17.
Dua SL. Peritoneal dialysis for isopropyl alcohol poisoning (letter). JAMA 1974; 230: 35.
Kaufman DB, DiNicola W, McIntosh R. Acute potassium dichromate poisoning. Treated by peritoneal dialysis. Am J Dis Child 1970; 119: 374–6.
Lichtenberg R, Zeller WP, Gatson R et al. Bromate poisoning. J Pediatr 1989; 114: 891–4.
Warshaw BL. Treatment of bromate poisoning. J Pediatr 1989; 115: 660–1.
Duo LJ, Zhi ZG, Ji LY. Peritoneal dialysis in the treatment of severe poisoning with organophosphorus pesticides: experience with twenty-two patients. Petit Dial Int 1990; 10: 242–3.
Kassa J. Use of peritoneal dialysis as a therapeutic method in poisoning by Neguvon. Cesko Farm 1990; 39: 7–10.
Yamamoto Y, Wakisaka O, Fujimoto S et al. Acute renal failure caused by ingestion of the carp gall bladder–a report of 3 cases, with special reference to the reported cases in Japan. J Jap Soc Intern Med 1988; 77: 1268–73.
Yium J, Martinez-Maldonado M, Eknoyan G et al. Peritoneal dialysis in the treatment of renal failure in multiple myeloma. South Med J 1971; 64: 1403–5.
Russell JA, Fitzharris BM, Corringham R et al. Plasma exchange versus peritoneal dialysis for removing Bence Jones protein. Br Med J 1978; 2: 1397.
Rosansky SJ, Richards FW. Use of peritoneal dialysis in the treatment of patients with renal failure and paraproteinemia. Am J Nephrol 1985; 5: 361–5.
Rose PE, McGonigle R, Michael J et al. Renal failure and the histopathological features of myeloma kidney reversed by intensive chemotherapy and peritoneal dialysis. Br Med J 1987; 294: 411–12.
Boyce NW, Holdsworth SR, Thomson NM et al. ‘Longterm’ survival in light-chain myeloma with dialysis therapy alone. Aust NZ J Med 1984; 14: 676–7.
Cosio FG, Pence RV, Shapiro FL et al. Severe renal failure in multiple myeloma. Clin Nephrol 1981; 15: 206–10.
Brown WW, Herbert LA, Piering WF et al. Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med 1979; 90: 793–4.
Johnson WJ, Kyle RA, Dahlberg PJ. Dialysis in the treatment of multiple myeloma. Mayo Clin Proc 1980; 55: 65–72.
Shetty A, Oreopoulos DG. Continuous ambulatory peritoneal dialysis in end-stage renal disease due to multiple myeloma. Petit Dial Int 1995; 15: 236–40.
Misra M, Goel S, Khanna R. Peritoneal dialyssi in patients with abdominal vascular prostheses. Adv Petit Dial 1998; 14: 95–7.
Vogt, J, Chlebowski H, Kniemeyer H-W, Grabensee B. Successful reinstitution of CAPD after retroperitoneal repair of an aortic aneurysm: a case report. Petit Dial Int 1995; 15: 71–2.
Goodship THJ, Lloyd S, McKenzie PW et al. Short-term studies on the use of amino acids as an osmotic agent in continuous ambulatory peritoneal dialysis. Clin Sci 1987; 73: 471–8.
Oreopoulos DG, Marliss EB, Anderson GH et al. Nutritional aspects of CAPD and the potential use of amino acid containing dialysis solutions. Petit Dial Bull 1983 (Suppl. 3 ): 510–12.
Mitwalli A, Rodella H, Brandes L et al. Is fat absorbed through the peritoneum? Petit Dial Bull 1985; 5: 165–8.
Pessa ME, Sitren HS, Copeland EM III et al. Nutritional support by intraperitoneal dialysis in the rat: maintenance of body weight with normal liver and plasma chemistries. J Parent Ent Nutr 1988; 12: 63–7.
Siriwardhana SA, Newfield AM, Lipton JM et al. Oxygen delivery by the peritoneal route. Can J Anesthes 1990; 37: 5159.
Shah BS. An in vitro model for chemical extraction of carbon dioxide via modified peritoneal dialysis. ASAIO Trans 1988; 34: 112–15.
Hoff CM, Shockley TR. The potential of gene therapy in the peritoneal cavity. Petit Dial Int 1999; 19 (Suppl. 2): in press.
Hoff CM, Cusick JL, Masse EM, Jackman RW, Nagy JA, Shockley TR. Modulation of transgene expression in mesothelial cells by activation of an inducible promoter. Nephrol Dial Transplant 1998; 13: 1420–4.
Jackman RW, Stapleton TD, Masse EM et al. Enhancement of the functional repertoire of the rat parietal peritoneal mesothelium In vivo: directed expression of the anticoagulant and antiinflammatory molecule thrombomodulin. Human Gene Therapy 1998; 9: 1069–81.
Hoff CM, Shockley TR. Genetic modification of the peritoneal membrane: potential for improving peritoneal dialysis through gene therapy. Semin Dial 1998; 11: 218–27.
Nagy JA, Shockley TR, Masse EM, Harvey VS, Hoff CM, Jackman RW. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Therapy 1995; 2: 402–10.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Prichard, S.S., Bargman, J.M. (2000). The use of peritoneal dialysis in special situations. In: Gokal, R., Khanna, R., Krediet, R.T., Nolph, K.D. (eds) Textbook of Peritoneal Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-3225-3_24
Download citation
DOI: https://doi.org/10.1007/978-94-017-3225-3_24
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-3227-7
Online ISBN: 978-94-017-3225-3
eBook Packages: Springer Book Archive